ID   SW780 FOXP3
AC   CVCL_C3GV
DR   GEO; GSM2143924
DR   GEO; GSM2143925
DR   GEO; GSM2143926
DR   Wikidata; Q114313076
RX   PubMed=27189164;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transfected with: HGNC; 6106; FOXP3.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1728 ! SW780
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=27189164; DOI=10.1158/1078-0432.CCR-15-2581;
RA   Zhang H.-W., Prado K., Zhang K.X., Peek E.M., Lee J., Wang X.-Y.,
RA   Huang J.-T., Li G., Pellegrini M., Chin A.I.;
RT   "Biased expression of the FOXP3Delta3 isoform in aggressive bladder
RT   cancer mediates differentiation and cisplatin chemotherapy
RT   resistance.";
RL   Clin. Cancer Res. 22:5349-5361(2016).
//